Medullary thyroid cancer: An experience from a tertiary care hospital of a developing country

Background: Medullary thyroid carcinoma (MTC) is a rare type of thyroid cancer that occasionally occurs as part of MEN2A. The universal treatment of MTC is total thyroidectomy with central lymph node dissection. For disease progression, carcinoembryonic antigen (CEA) and calcitonin (CTN) need to be...

Full description

Bibliographic Details
Main Authors: Sajjad A Khan, Abdul Aziz, Umer A Esbhani, Muhammad Q Masood
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2022-01-01
Series:Indian Journal of Endocrinology and Metabolism
Subjects:
Online Access:http://www.ijem.in/article.asp?issn=2230-8210;year=2022;volume=26;issue=1;spage=68;epage=72;aulast=Khan
_version_ 1818234189093273600
author Sajjad A Khan
Abdul Aziz
Umer A Esbhani
Muhammad Q Masood
author_facet Sajjad A Khan
Abdul Aziz
Umer A Esbhani
Muhammad Q Masood
author_sort Sajjad A Khan
collection DOAJ
description Background: Medullary thyroid carcinoma (MTC) is a rare type of thyroid cancer that occasionally occurs as part of MEN2A. The universal treatment of MTC is total thyroidectomy with central lymph node dissection. For disease progression, carcinoembryonic antigen (CEA) and calcitonin (CTN) need to be followed. Our aim was to study the presence and patterns of the above-mentioned characteristics of MTC in our population. Methodology: This retrospective study was conducted in a tertiary care hospital of Pakistan in which data of thirty-two medullary thyroid cancer patients over the past 20 years were reviewed and analysed after fulfilment of inclusion criteria. Their clinical, pathological, biochemical and treatment modalities were recorded through a retrospective review of their medical record files. Results: The mean age of patients was 42.88 ± 2.67 years in our study, with a male-to-female ratio of 2:1. Patients with sporadic MTC were 68.8%, while 31.2% were familial. The rates of metastasis were highest in bones followed by lungs and liver. Total thyroidectomy was performed in 26 (81.2%) patients and among those chemotherapy and XRT were performed in one and two patients, respectively. Histologically, the mean tumour size was 7.62 ± 3.64 cm. Median pre-surgery calcitonin was 5756 pg/ml that decreased to 29.3 pg/ml post-surgery. Median pre-surgery CEA level was 246.5 ng/ml that decreased to 6.39 ng/ml post-surgery. Two patients were RET positive. Conclusion: MTC usually presents in the fourth decade of life with male predominance and mostly sporadic occurrence. Total thyroidectomy with subsequent serial calcitonin and CEA levels thereafter are the mainstay of treatment and follow-up.
first_indexed 2024-12-12T11:34:07Z
format Article
id doaj.art-3f1f8a422fe249ef934d9226bd8fa3ec
institution Directory Open Access Journal
issn 2230-8210
language English
last_indexed 2024-12-12T11:34:07Z
publishDate 2022-01-01
publisher Wolters Kluwer Medknow Publications
record_format Article
series Indian Journal of Endocrinology and Metabolism
spelling doaj.art-3f1f8a422fe249ef934d9226bd8fa3ec2022-12-22T00:25:42ZengWolters Kluwer Medknow PublicationsIndian Journal of Endocrinology and Metabolism2230-82102022-01-01261687210.4103/ijem.ijem_474_21Medullary thyroid cancer: An experience from a tertiary care hospital of a developing countrySajjad A KhanAbdul AzizUmer A EsbhaniMuhammad Q MasoodBackground: Medullary thyroid carcinoma (MTC) is a rare type of thyroid cancer that occasionally occurs as part of MEN2A. The universal treatment of MTC is total thyroidectomy with central lymph node dissection. For disease progression, carcinoembryonic antigen (CEA) and calcitonin (CTN) need to be followed. Our aim was to study the presence and patterns of the above-mentioned characteristics of MTC in our population. Methodology: This retrospective study was conducted in a tertiary care hospital of Pakistan in which data of thirty-two medullary thyroid cancer patients over the past 20 years were reviewed and analysed after fulfilment of inclusion criteria. Their clinical, pathological, biochemical and treatment modalities were recorded through a retrospective review of their medical record files. Results: The mean age of patients was 42.88 ± 2.67 years in our study, with a male-to-female ratio of 2:1. Patients with sporadic MTC were 68.8%, while 31.2% were familial. The rates of metastasis were highest in bones followed by lungs and liver. Total thyroidectomy was performed in 26 (81.2%) patients and among those chemotherapy and XRT were performed in one and two patients, respectively. Histologically, the mean tumour size was 7.62 ± 3.64 cm. Median pre-surgery calcitonin was 5756 pg/ml that decreased to 29.3 pg/ml post-surgery. Median pre-surgery CEA level was 246.5 ng/ml that decreased to 6.39 ng/ml post-surgery. Two patients were RET positive. Conclusion: MTC usually presents in the fourth decade of life with male predominance and mostly sporadic occurrence. Total thyroidectomy with subsequent serial calcitonin and CEA levels thereafter are the mainstay of treatment and follow-up.http://www.ijem.in/article.asp?issn=2230-8210;year=2022;volume=26;issue=1;spage=68;epage=72;aulast=Khanclinicopathological characteristicsdeveloping countrymedullary thyroid cancer
spellingShingle Sajjad A Khan
Abdul Aziz
Umer A Esbhani
Muhammad Q Masood
Medullary thyroid cancer: An experience from a tertiary care hospital of a developing country
Indian Journal of Endocrinology and Metabolism
clinicopathological characteristics
developing country
medullary thyroid cancer
title Medullary thyroid cancer: An experience from a tertiary care hospital of a developing country
title_full Medullary thyroid cancer: An experience from a tertiary care hospital of a developing country
title_fullStr Medullary thyroid cancer: An experience from a tertiary care hospital of a developing country
title_full_unstemmed Medullary thyroid cancer: An experience from a tertiary care hospital of a developing country
title_short Medullary thyroid cancer: An experience from a tertiary care hospital of a developing country
title_sort medullary thyroid cancer an experience from a tertiary care hospital of a developing country
topic clinicopathological characteristics
developing country
medullary thyroid cancer
url http://www.ijem.in/article.asp?issn=2230-8210;year=2022;volume=26;issue=1;spage=68;epage=72;aulast=Khan
work_keys_str_mv AT sajjadakhan medullarythyroidcanceranexperiencefromatertiarycarehospitalofadevelopingcountry
AT abdulaziz medullarythyroidcanceranexperiencefromatertiarycarehospitalofadevelopingcountry
AT umeraesbhani medullarythyroidcanceranexperiencefromatertiarycarehospitalofadevelopingcountry
AT muhammadqmasood medullarythyroidcanceranexperiencefromatertiarycarehospitalofadevelopingcountry